Drugs / Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00996138 | Sep → Nov 2009 | influenza | Novartis Vaccines | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00996138 ↗ |
| Modality | Vaccine | “cell culture-derived MF59(®)-adjuvanted A/H1N1 pandemic vaccine” PMID 22472791 ↗ Apr 2012 |